Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

BEAM

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-26Shares Purchased (TTM):0Shares Sold (TTM):457,353

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:104,467,313Shares Outstanding:103,262,001Institutional Ownership Pct.:101.17%

Earnings Market Reaction:

Filing Date:2026-08-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	220	288	295	268	282	528	282	230	293	288	436	169
Marketable Securities Current	933	923	950	807	868	692	569	696	715	807	-	846
Prepaid Expense And Other Assets Current	26	55	23	24	25	28	27	20	21	27	21	24
Assets Current	1,179	1,267	1,269	1,099	1,175	1,248	878	946	1,029	1,122	1,211	1,040
Property Plant And Equipment Net	98	101	105	108	109	110	111	114	117	121	125	128
Restricted Cash Noncurrent	7	7	7	7	7	7	8	7	6	6	9	9
Operating Lease Right Of Use Asset	96	98	101	97	100	102	105	105	107	109	113	112
Other Assets Noncurrent	8	8	1	1	1	1	1	1	1	2	2	3
Assets	1,386	1,481	1,481	1,311	1,391	1,467	1,104	1,171	1,261	1,360	1,460	1,291
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	13	12	10	10	11	8	4	4	4	3	2	3
Accrued Liabilities And Other Liabilities	40	39	55	42	41	30	47	52	67	86	-	42
Derivative Liabilities Current	9	5	8	7	4	5	8	8	8	14	11	9
Contract With Customer Liability Current	0	0	7	110	106	85	109	89	85	72	69	153
Operating Lease Liability Current	15	15	14	13	13	13	13	13	13	12	13	12
Finance Lease Liability Current	-	-	-	-	-	-	-	-	-	-	-	1
Business Combination Contingent Consideration Liab…	3	3	3	1	-	-	-	-	-	-	-	-
Liabilities Current	81	75	97	183	174	142	182	166	177	187	206	220
Operating Lease Liability Noncurrent	132	136	140	139	142	145	148	149	153	156	160	161
Finance Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	-	0
Business Combination Contingent Consideration Liab…	6	5	6	7	1	1	1	1	1	3	3	5
Contract With Customer Liability Noncurrent	-	-	0	10	20	49	33	58	75	100	110	125
Derivative Liabilities Noncurrent	-	-	0	7	6	6	5	5	-	-	-	-
Long Term Debt Noncurrent	100	100	-	-	-	-	-	-	-	-	-	-
Other Liabilities Noncurrent	0	0	0	0	0	0	1	0	1	1	0	1
Liabilities	319	316	243	345	344	344	370	380	407	446	478	512
Stockholders Equity
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital	2,927	2,900	2,877	2,855	2,824	2,798	2,299	2,265	2,234	2,202	2,170	2,113
Accumulated Other Comprehensive Income Loss Net Of…	-2	-1	1	1	0	0	1	2	-1	-1	1	-2
Retained Earnings Accumulated Deficit	-1,858	-1,736	-1,641	-1,891	-1,778	-1,676	-1,567	-1,476	-1,380	-1,289	-1,190	-1,333
Stockholders Equity	1,067	1,164	1,238	966	1,053	1,129	734	791	854	913	981	779
Liabilities And Stockholders Equity	1,386	1,481	1,481	1,311	1,391	1,467	1,104	1,171	1,261	1,360	1,460	1,291
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	25	25	25	25	25	25	25	25	25	25	25	25
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	250	250	250	250	250	250	250	250	250	250	250	250
Common Stock Shares Issued	103	103	102	101	101	101	84	83	82	82	82	79
Shares Outstanding	103	103	102	101	101	101	84	83	82	82	82	79

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	4.64%	10.61%	-20.24%	-	-	-	-	-	-	-	-	-
2025	-1.00%	5.07%	35.83%	-12.51%	22.83%	49.52%	11.39%	23.04%	38.79%	-23.72%	-2.79%	-13.50%
2024	5.73%	3.99%	47.09%	4.55%	-1.84%	-15.56%	14.38%	11.12%	8.57%	-21.92%	-43.03%	-40.05%
2023	-	-	-	-10.63%	-8.38%	-29.07%	29.13%	18.86%	6.07%	-25.38%	-46.97%	-45.37%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	14.57	16.99	13.09	6.02	6.75	8.81	4.82	5.69	5.81	5.99	5.89	4.72
Quick Ratio	14.25	16.25	12.85	5.89	6.61	8.62	4.67	5.57	5.69	5.85	5.79	4.61
Working Capital	1.10B	1.19B	1.17B	915.99M	1.00B	1.11B	696.08M	779.29M	852.11M	934.49M	1.01B	819.18M
Leverage & Debt
Debt to Equity	0.30	0.27	0.20	0.36	0.33	0.30	0.50	0.48	0.48	0.49	0.49	0.66
Debt Ratio	0.23	0.21	0.16	0.26	0.25	0.23	0.34	0.32	0.32	0.33	0.33	0.40
Efficiency & Turnover
Asset Turnover TTM	0.11	0.11	0.11	0.04	0.05	0.04	0.05	0.28	0.27	0.27	0.27	0.06
Per Share Metrics
Diluted EPS TTM	-0.83	-0.64	-0.81	-4.03	-3.90	-4.39	-4.58	-1.74	-1.74	-1.65	-1.72	-3.97
Free Cash Flow Per Share TTM	-3.34	-3.72	-3.64	-2.39	-2.44	-4.10	-4.33	-1.76	-1.86	-2.07	-2.37	-4.96
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-242.27%	-226.58%	-274.57%	-837.12%	-739.94%	-677.47%	-654.25%	-52.25%	-52.31%	-50.34%	-46.73%	-488.42%
Net Profit Margin TTM	-55.45%	-40.23%	-57.24%	-742.45%	-659.49%	-607.76%	-593.13%	-41.07%	-40.56%	-37.33%	-35.09%	-384.62%
Growth Metrics
Net Revenue Growth (1Y)	158.88%	157.97%	120.01%	-84.07%	-82.90%	-82.38%	-83.18%	328.73%	339.83%	370.57%	520.01%	-11.31%
Net Income Growth (1Y)	-78.23%	-82.92%	-78.77%	188.01%	177.94%	186.79%	184.28%	-54.22%	-56.29%	-57.41%	-54.16%	-0.56%
EPS Growth (1Y)	-78.72%	-85.45%	-82.33%	131.40%	124.31%	166.32%	166.45%	-56.10%	-59.46%	-62.32%	-58.40%	-11.49%
Valuation Metrics
P/E TTM	-41.38	-37.30	-34.27	-6.02	-4.36	-4.45	-5.42	-14.06	-13.49	-20.03	-15.85	-6.06
P/B TTM	3.35	2.11	2.21	2.58	1.65	1.52	2.78	2.55	2.26	2.95	2.14	2.44
P/S TTM	22.95	15.00	19.62	44.69	28.79	27.02	32.14	5.77	5.47	7.48	5.56	23.30
Market Cap	3.58B	2.46B	2.74B	2.49B	1.73B	1.72B	2.04B	2.02B	1.93B	2.70B	2.10B	1.90B
Enterprise Value	3.45B	2.27B	2.44B	2.21B	1.45B	1.18B	1.75B	1.78B	1.63B	2.41B	1.66B	1.72B
Calculated Values
Free Cash Flow TTM	-348.97M	-383.84M	-360.05M	-245.41M	-248.62M	-360.96M	-356.19M	-145.37M	-153.40M	-169.28M	-182.93M	-391.86M
Net Debt	-126.28M	-194.79M	-301.62M	-274.62M	-288.77M	-534.52M	-290.11M	-236.75M	-298.92M	-294.30M	-444.61M	-176.34M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-26Sale

Owner: Fmr, Llc

Title: -

Shares: 251,488

Price/Share: $35.26

Value: $8,867,466.88

Shares Owned: 854,583

Relationship: TenPercentOwner,Other

Ownership: Indirect

2026-04-01Sale

Owner: Simon, Amy

Title: Chief Medical Officer

Shares: 6,700

Price/Share: $24.58

Value: $164,686.00

Shares Owned: 102,735

Relationship: Officer

Ownership: Direct

2026-04-01Sale

Owner: Ciaramella, Giuseppe

Title: President

Shares: 11,810

Price/Share: $24.58

Value: $290,289.80

Shares Owned: 218,406

Relationship: Officer

Ownership: Direct

2026-04-01Sale

Owner: Evans, John M.

Title: CEO

Shares: 30,078

Price/Share: $24.58

Value: $739,317.24

Shares Owned: 1,047,205

Relationship: Director,Officer

Ownership: Direct

2026-04-01Sale

Owner: Cavanagh, Bethany J

Title: SVP, Finance and Treasurer

Shares: 3,242

Price/Share: $24.58

Value: $79,688.36

Shares Owned: 51,171

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-26	Fmr, Llc	TenPercentOwner,Other	-	Indirect	Sale	251,488	35.26	$8,867,466.88	854,583	4
2026-04-01	Simon, Amy	Officer	Chief Medical Officer	Direct	Sale	6,700	24.58	$164,686.00	102,735	4
2026-04-01	Ciaramella, Giuseppe	Officer	President	Direct	Sale	11,810	24.58	$290,289.80	218,406	4
2026-04-01	Evans, John M.	Director,Officer	CEO	Direct	Sale	30,078	24.58	$739,317.24	1,047,205	4
2026-04-01	Cavanagh, Bethany J	Officer	SVP, Finance and Treasurer	Direct	Sale	3,242	24.58	$79,688.36	51,171	4
2026-04-01	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	5,956	24.58	$146,398.48	109,711	4
2026-03-31	Evans, John M.	Director,Officer	CEO	Direct	Sale	25,000	22.76	$569,000.00	986,667	4
2026-02-24	Ciaramella, Giuseppe	Officer	President	Direct	Sale	35,000	32.00	$1,120,000.00	190,216	4
2026-01-30	Evans, John M.	Director,Officer	CEO	Direct	Sale	25,000	28.64	$716,000.00	986,667	4
2026-01-22	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	1,371	34.00	$46,614.00	95,667	4
2026-01-22	Cavanagh, Bethany J	Officer	SVP, Finance and Treasurer	Direct	Sale	6,198	35.00	$216,930.00	34,813	4
2026-01-20	Cavanagh, Bethany J	Officer	SVP, Finance and Treasurer	Direct	Sale	3,034	30.12	$91,384.08	41,011	4
2026-01-15	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	18,629	34.58	$644,190.82	97,038	4
2025-12-31	Emany, Sravan Kumar	Officer	Chief Financial Officer	Direct	Sale	6,294	27.10	$170,567.40	73,706	4
2025-12-31	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	1,254	27.10	$33,983.40	115,667	4
2025-10-27	Fmr, Llc	TenPercentOwner,Other	-	Indirect	Sale	459	26.68	$12,246.12	14	4
2025-10-02	Evans, John M.	Director,Officer	CEO	Direct	Sale	25,000	24.63	$615,750.00	986,667	4
2025-10-01	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	373	24.53	$9,149.69	116,921	4
2025-10-01	Cavanagh, Bethany J	Officer	SVP, Finance and Treasurer	Direct	Sale	467	24.53	$11,455.51	44,045	4
2025-07-30	Fmr, Llc	TenPercentOwner,Other	-	Indirect	Sale	48,374	20.50	$991,667.00	2,073,665	4
2025-07-03	Simon, Amy	Officer	Chief Medical Officer	Direct	Sale	876	20.12	$17,625.12	64,864	4
2025-04-02	Simon, Amy	Officer	Chief Medical Officer	Direct	Sale	20,997	17.73	$372,276.81	65,742	4
2025-04-01	Cavanagh, Bethany J	Officer	SVP, Finance and Treasurer	Direct	Sale	3,015	18.35	$55,325.25	44,512	4
2025-04-01	Ciaramella, Giuseppe	Officer	President	Direct	Sale	7,434	18.35	$136,413.90	190,216	4
2025-04-01	Evans, John M.	Director,Officer	CEO	Direct	Sale	30,663	18.35	$562,666.05	986,249	4
2025-04-01	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	5,674	18.35	$104,117.90	117,294	4
2025-02-18	Cavanagh, Bethany J	Officer	SVP, Finance and Treasurer	Direct	Sale	6,287	35.00	$220,045.00	37,527	4
2025-02-14	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	10,000	34.00	$340,000.00	102,968	4
2025-01-30	Evans, John M.	Director,Officer	CEO	Direct	Sale	30,000	27.02	$810,600.00	908,659	4
2025-01-02	Cavanagh, Bethany J	Officer	SVP, Finance and Treasurer	Direct	Sale	1,117	24.68	$27,567.56	43,814	4
2025-01-02	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	1,241	24.68	$30,627.88	102,968	4
2024-11-06	Ciaramella, Giuseppe	Officer	President	Direct	Sale	51,110	26.36	$1,347,259.60	109,150	4
2024-10-14	Ciaramella, Giuseppe	Officer	President	Direct	Sale	51,110	26.27	$1,342,659.70	160,260	4
2024-10-01	Cavanagh, Bethany J	Officer	SVP, Finance and Treasurer	Direct	Sale	289	23.48	$6,785.72	44,931	4
2024-10-01	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	385	23.48	$9,039.80	104,209	4
2024-09-30	Evans, John M.	Director,Officer	CEO	Direct	Sale	60,000	24.60	$1,476,000.00	938,659	4
2024-07-02	Simon, Amy	Officer	Chief Medical Officer	Direct	Sale	748	22.95	$17,166.60	68,805	4
2024-06-27	Evans, John M.	Director,Officer	CEO	Direct	Sale	60,000	24.50	$1,470,000.00	998,343	4
2024-04-02	Simon, Amy	Officer	Chief Medical Officer	Direct	Sale	16,530	30.54	$504,826.20	70,060	4
2024-04-01	Evans, John M.	Director,Officer	CEO	Direct	Sale	18,102	32.13	$581,617.26	1,058,343	4
2024-04-01	Ciaramella, Giuseppe	Officer	President	Direct	Sale	4,534	32.12	$145,632.08	169,616	4
2024-04-01	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	3,401	32.12	$109,240.12	104,594	4
2024-04-01	Burrell, Terry-Ann	Officer	Chief Financial Officer	Direct	Sale	5,446	32.12	$174,925.52	70,137	4
2024-03-28	Evans, John M.	Director,Officer	CEO	Direct	Sale	60,000	33.86	$2,031,600.00	998,262	4
2024-02-14	Fmr, Llc	Other	-	Indirect	Sale	900,000	30.92	$27,828,000.00	1,235,511	4
2024-01-31	Evans, John M.	Director,Officer	CEO	Direct	Sale	60,000	25.33	$1,519,800.00	1,058,262	4
2024-01-03	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	1,907	26.42	$50,382.94	80,495	4
2023-11-20	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	10,000	30.50	$305,000.00	82,402	4
2023-10-30	Simon, Amy	Officer	Chief Medical Officer	Direct	Sale	3,448	18.70	$64,477.60	65,469	4
2023-10-02	Bellon, Christine	Officer	Chief Legal Officer	Direct	Sale	388	22.85	$8,865.80	82,402	4
2023-07-24	Ciaramella, Giuseppe	Officer	President and CSO	Direct	Sale	1,206	32.01	$38,604.06	48,250	4
2023-07-10	Simon, Amy	Officer	Chief Medical Officer	Direct	Sale	391	30.48	$11,917.68	68,917	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

101.17%

Inst. Shares: 104,467,313

Shares Outstanding: 103,262,001

2025-12-31

104.78%

Inst. Shares: 103,637,009

Shares Outstanding: 98,905,577

2025-09-30

101.34%

Inst. Shares: 103,943,817

Shares Outstanding: 102,570,801

2025-06-30

102.77%

Inst. Shares: 104,818,716

Shares Outstanding: 101,995,184

2025-03-31

111.37%

Inst. Shares: 97,976,563

Shares Outstanding: 87,975,311

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	104,467,313	103,262,001	101.17%
2025-12-31	103,637,009	98,905,577	104.78%
2025-09-30	103,943,817	102,570,801	101.34%
2025-06-30	104,818,716	101,995,184	102.77%
2025-03-31	97,976,563	87,975,311	111.37%
2024-12-31	79,189,703	82,313,008	96.21%
2024-09-30	76,959,458	82,410,095	93.39%
2024-06-30	75,761,135	82,312,467	92.04%
2024-03-31	68,282,770	81,698,633	83.58%
2023-12-31	68,304,044	77,151,771	88.53%
2023-09-30	66,373,327	79,024,647	83.99%
2023-06-30	63,236,852	76,335,175	82.84%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Beam Therapeutics Inc. (BEAM) — SEC Financial Statements & Analysis

Beam Therapeutics Inc. (BEAM) is a biological products, (no diagnostic substances) company, incorporated in DE. Beam Therapeutics Inc. trades on Nasdaq as: BEAM. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Beam Therapeutics Inc. reported a 158.88% year-over-year revenue growth, a Debt-to-Equity ratio of 0.30x, a Price-to-Sales (P/S) ratio of 22.95x (TTM), a Price-to-Book (P/B) ratio of 3.35x (TTM), at a market cap of $3.58B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 158.88%
Debt To Equity: 0.30x
P/S TTM: 22.95x
P/B TTM: 3.35x
Market Cap: $3.58B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Beam Therapeutics Inc. in?

Beam Therapeutics Inc. (BEAM) operates in the Biological Products, (No Diagnostic Substances) industry.

What is BEAM's market cap?

Beam Therapeutics Inc. (BEAM) has a market capitalization of $3.58B as of 2026-06-30.

What exchange does BEAM trade on?

Beam Therapeutics Inc. (BEAM) trades on the Nasdaq.

Where is Beam Therapeutics Inc. incorporated?

Beam Therapeutics Inc. is incorporated in DE.